PGIM Jennison Focused Growth ETF (NYSEARCA:PJFG – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 2,246 shares, an increase of 1,063.7% from the September 30th total of 193 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 1,939 shares, the days-to-cover ratio is currently 1.2 days.
PGIM Jennison Focused Growth ETF Stock Up 0.4%
PJFG stock traded up $0.43 during midday trading on Tuesday, reaching $117.58. The company had a trading volume of 407 shares, compared to its average volume of 3,373. The firm has a market capitalization of $142.27 million, a PE ratio of 39.69 and a beta of 1.28. The stock has a 50 day moving average price of $119.11 and a 200 day moving average price of $112.36. PGIM Jennison Focused Growth ETF has a fifty-two week low of $93.67 and a fifty-two week high of $124.65.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in PGIM Jennison Focused Growth ETF stock. Kestra Advisory Services LLC boosted its stake in PGIM Jennison Focused Growth ETF (NYSEARCA:PJFG – Free Report) by 1,051.2% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,901 shares of the company’s stock after buying an additional 2,649 shares during the period. Kestra Advisory Services LLC owned 0.22% of PGIM Jennison Focused Growth ETF worth $282,000 at the end of the most recent quarter.
PGIM Jennison Focused Growth ETF Company Profile
The PGIM Jennison Focused Growth ETF (PJFG) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to a narrow basket of growth stocks from all over the world. PJFG was launched on Dec 12, 2022 and is managed by PGIM.
Further Reading
- Five stocks we like better than PGIM Jennison Focused Growth ETF
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
- Intel’s $155 Price Target Raises a Bigger Question About Its Turnaround Potential
Receive News & Ratings for PGIM Jennison Focused Growth ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PGIM Jennison Focused Growth ETF and related companies with MarketBeat.com's FREE daily email newsletter.
